Retinol-binding protein-4 (RBP4) accurately classified 204 healthy controls and 228 RA patients in predicted classes, with a classification accuracy of 90.8% and 86.0% for healthy controls and RA patients, respectively (Fig. 6a). The gene discussed is RBP4; the disease is rheumatoid arthritis.